Tag Archives: NXTM

Best Clean Energy Stocks To Watch For 2018

President and CEO of Charles Schwab Corp (NYSE:SCHW) Walter W Bettinger sold 168,220 shares of SCHW on 11/30/2017 at an average price of $49.1 a share. The total sale was $8.3 million.

Charles Schwab Corp through its subsidiaries provides retail brokerage and banking, retirement plan, and other corporate brokerage services. The company’s operating business segments are Investor Services and Advisor Services. Charles Schwab Corp has a market cap of $65.41 billion; its shares were traded at around $48.79 with a P/E ratio of 31.28 and P/S ratio of 7.88. The dividend yield of Charles Schwab Corp stocks is 0.64%. Charles Schwab Corp had annual average EBITDA growth of 4.40% over the past ten years.

CEO Recent Trades:

President and CEO Walter W Bettinger bought 72,510 shares of SCHW stock on 11/07/2017 at the average price of $27.21. The price of the stock has increased by 79.31% since.President and CEO Walter W Bettinger sold 168,220 shares of SCHW stock on 11/30/2017 at the average price of $49.1. The price of the stock has decreased by 0.63% since.President and CEO Walter W Bettinger sold 262,309 shares of SCHW stock on 11/29/2017 at the average price of $48.15. The price of the stock has increased by 1.33% since.

CFO Recent Trades:

Best Clean Energy Stocks To Watch For 2018: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group in an uptrend for the past two year, but also under performingpeerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX):

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group along with peersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)all taking offlast year albeit MRVL has underperformed ETF benchmarks:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group under performingpeersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)will all taking offlast year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group peaking in early 2015 while peerSTMicroelectronics NV (NYSE: STM) hasnt performed much better and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) have performed better:

Best Clean Energy Stocks To Watch For 2018: PHI, Inc.(PHIIK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap offshore oil and gas services stock PHI Inc (NASDAQ: PHIIK):

    We’re a little bit late to the party here, but that’s ok – there’s still some meat left on the bone, so to speak. Were looking for the stock to continue on to the lower edge of a long-term (and bearish) trading range that should allow it to peel back to at least the lower $12’s. We’ve see PHIIK shares tumble with great speed and distance a couple of times already, and we’re about halfway through round three.

Best Clean Energy Stocks To Watch For 2018: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

Best Clean Energy Stocks To Watch For 2018: FMC Corporation(FMC)

Advisors’ Opinion:

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

Top 10 Clean Energy Stocks To Own Right Now

Related GSAT What The Comcast/Charter Deal Means For Wireless, Spectrum Companies Speculative Short To M&A Darling, A Look Back At StraightPath Communications Journey
Related Earnings Scheduled For March 21, 2017 The Market In 5 Minutes

Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity.

Here's a recap of the options alerts from Friday, May 12, 2017. All time stamps are in Eastern Time.

3:14:44 pm: GSAT GlobalStar Jun 2.5 Calls Sweep: 1000 @ Above Ask! $0.325: 21k traded vs 2514 OI: Earnings 8/3 Before Open [est] $2.40 Ref

3:11:17 pm: LE Land's End Jun 20.0 Puts Sweep: 1273 @ ASK $1.05: 1273 traded vs 988 OI: Earnings 5/31 Before Open [est] $20.80 Ref

2:36:08 pm: FTNT Fortinet May 40.0 Calls Sweep: 997 @ ASK $0.25: 1004 traded vs 702 OI: Earnings 7/27 After Close [est] $39.13 Ref

12:51:05 pm: GSAT GlobalStar May 2.0 Calls: 1274 @ ASK $0.15: 1719 traded vs 5282 OI: Earnings 8/3 Before Open [est] $1.93 Ref

Top 10 Clean Energy Stocks To Own Right Now: Natural Grocers by Vitamin Cottage, Inc.(NGVC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart for Whole Foods Market shows shares still lower than they were five years ago whilepeers in the organic space like Sprouts Farmers Market Inc (NASDAQ: SFM) and Natural Grocers by Vitamin Cottage (NYSE: NGVC) have performed worst:

  • [By Peter Graham]

    A long term performance chart for Whole Foods Market shows along with mid cap peerSprouts Farmers Market Inc (NASDAQ: SFM) and Natural Grocers by Vitamin Cottage (NYSE: NGVC) largely drifting lower with two price spikes:

  • [By Peter Graham]

    A long term performance chart for Whole Foods Market shows along with mid cap peerSprouts Farmers Market Inc (NASDAQ: SFM) and Natural Grocers by Vitamin Cottage (NYSE: NGVC) appearing to all be in downtrends that may or may not have leveled off:

  • [By Lisa Levin]

    Natural Grocers by Vitamin Cottage Inc (NYSE: NGVC) was down, falling around 33 percent to $5.70 as the company posted downbeat quarterly results and lowered its FY17 earnings guidance.

Top 10 Clean Energy Stocks To Own Right Now: Sigma Designs, Inc.(SIGM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sigma Designs Inc. (NASDAQ: SIGM) dropped about 34% on Wednesday to post a new 52-week low of $5.20 against a 52-week high of $8.60 and a Tuesday close of $7.75. Volume of about 6.2 million was about 25 times the daily average of around 280,000. The company reported so-so earnings on Tuesday and the stock was downgraded and price targets lowered by several analysts.

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

  • [By Lisa Levin]

    Sigma Designs Inc (NASDAQ: SIGM) shares dropped 30 percent to $5.43. Sigma Designs reported fiscal third-quarter net income of $221,000 on revenue of $62.7 million.

Top 10 Clean Energy Stocks To Own Right Now: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

Top 10 Clean Energy Stocks To Own Right Now: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Denver, Colorado-based CoreSite Realty Corporation (COR) offers cloud-enabled, high-performance data center campuses.

    Operating across 17 data centers in eight key North American markets, CoreSite serves a broad range of clients, including telecommunications carriers, media companies, financial and educational institutions, and government agencies.

Top 10 Clean Energy Stocks To Own Right Now: Theravance Biopharma, Inc.(TBPH)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    The exact date Theravance Biopharma Inc. (TBPH) intends to release a phase 3 update on COPD treatment Revefenacin isnt known. The company simply said in a prior communication with the market it would be sharing an interim look at the trials progress sometime in early Q4.

Top 10 Clean Energy Stocks To Own Right Now: QC Holdings Inc.(QCCO)

Advisors’ Opinion:

  • [By Monica Gerson]

    QC Holdings (NASDAQ: QCCO) shares tumbled 2.58% to reach a new 52-week low of $2.27. QC Holdings’ trailing-twelve-month profit margin is 0.60%.

    NewLead Holdings (NASDAQ: NEWL) shares dipped 6.56% to touch a new 52-week low of $0.08 after the company completed the acquisition of titles in the Viking Mine located in Kentucky, USA.

Top 10 Clean Energy Stocks To Own Right Now: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

Top 10 Clean Energy Stocks To Own Right Now: Innoviva, Inc. (INVA)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of Innoviva (NASDAQ:INVA), a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline’s (NYSE:GSK) development partner for its multiple next-generation COPD and asthma products, fell as much as 11% on Thursday. The reason behind Innoviva’s bad day can be traced to a proxy battle with activist hedge fund Sarissa Capital Management over seats on its board.

Top 10 Clean Energy Stocks To Own Right Now: The NASDAQ OMX Group Inc.(NDAQ)

Advisors’ Opinion:

  • [By Jake Zamansky]

    The Securities and Exchange Commission said on Wednesday afternoon it was in contact with the NASDAQ OMX Group (NDAQ) after the brief outage in the system that was at the heart of the three hour shutdown in August, according to a report by Reuters.

  • [By Maureen Farrell]

    Twitter will try not to mimic Facebook’s mistakes on IPO day.

    NEW YORK (CNNMoney) At the start of last year, Nasdaq (NDAQ) and Morgan Stanley (MS, Fortune 500) were on top of the tech world. Both landed key roles in Facebook’s hotly anticipated initial public offering.

    But Facebook’s IPO changed that. Both companies were widely criticized for Facebook’s face plant of a debut. The problems that marred Facebook’s IPO clearly hurt the image of Nasdaq and Morgan Stanley.

  • [By Brent Slava]

    Power Solutions International Inc (NASDAQ: PSIX) shares plunged as much as 30 percent Tuesday on a report the company would be delisting from Nasdaq Inc (NASDAQ: NDAQ).

  • [By Hibah Yousuf]

    In a report outlining the growing operational risks at trading exchanges, S&P said the noticeable increase in technical snafus could trigger ratings downgrades for major operators like NYSE Euronext (NYX), Nasdaq OMX (NDAQ) and BATS Global Markets over the next few years.

  • [By CNNMoney Staff]

    Stocks continued to rally despite the fact that options trading was temporarily halted Monday afternoon at exchanges run by CBOE Holdings (CBOE), Nasdaq OMX (NDAQ), BATS Global Markets and Miami International Holdings due to issues at the Options Price Reporting Authority (OPRA), which provides trading data and price quotes.

  • [By David Zeiler]

    Bitcoin futures trading started at the CBOE Global Markets Inc. (Nasdaq: CBOE) on Dec. 10 and on the much larger CME Group Inc. (Nasdaq: CME) on Dec. 18. Nasdaq Inc. (Nasdaq: NDAQ) plans to begin trading Bitcoin futures in the first half of next year.

Top 10 Clean Energy Stocks To Own Right Now: Energy Focus, Inc.(EFOI)

Advisors’ Opinion:

  • [By Peter Graham]

    Meanwhile, small cap Energy Focus Inc (NASDAQ: EFOI) calls itself an industry-leading innovator of energy-efficient LED lighting technology that aims to be the trusted leader in LED lighting retrofit. As the creator of the first, and so far, only UL-verified low-flicker LED products on the U.S. market, Energy Focus products provide extensive energy and maintenance savings, and aesthetics, safety, health and sustainability benefits over conventional lighting. Customers include national, state and local U.S. government agencies (thanks to numerous research and development projects for the DOE and DARPA) as well as Fortune 500 companies, the U.S. Navy and many others.

  • [By Lisa Levin]

    Shares of Energy Focus Inc (NASDAQ: EFOI) were down 40 percent to $7.95 after the company reported weaker-than-expected Q4 results.

    Omega Protein Corporation (NYSE: OME) was down, falling around 20 percent to $17.47 after the company reported weaker-than-expected results for its fourth quarter.

great stock investments

After to plunging to a 30-year low, the Deutsche stock price has climbed 18.55% in the last five days.

But we don’t recommend buying in on this week’s Deutsche stock price rally…

Before we get into why we remain bearish on Deutsche Bank AG (NYSE: DB), here’s what has been driving shares so much higher this week…

Why the Deutsche Stock Price Has Rebounded

The Deutsche Bank stock price had been falling after U.S. regulators said they are seeking $14 billion in fines from the company for selling fraudulent mortgages that lead to the U.S. housing bubble.

But new reports this week indicate that the fine may actually be closer to $5.4 billion. Apparently the bank’s transgressions may not have been as bad as originally determined.

great stock investments: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

great stock investments: Nestl茅 S.A. (NSRGF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In sum, the three companies are equally valued at generous multiples. It is difficult to choose one of them based on fundamentals or valuations, but we like the strategy of Nestl茅 and P&G more than Unilever. Therefore, we recommend investing in these companies only if someone is interested in a limited but relatively safe upside potential. Good entry prices would be as follows: Nestl茅 (OTCPK:NSRGF) at CHF 70.1 or $70.1 for the ADR , P&G at $83.6 and Unilever (OTC:UNLVF) at 34.1 or $38 for the ADR (NYSE:UN).

  • [By SEEKINGALPHA.COM]

    A recently updated map from HowMuch.net ranking the world’s most valuable brands by country in 2017 shows that Apple Inc. (AAPL) lost its spot as the US’s most valuable brand. Of these, the top 10 most valuable brands with shares or ADRs traded in the US are:

    US-based search engine and Google parent Alphabet Inc (GOOG) (NASDAQ:GOOGL) Swiss food giant Nestle (OTCPK:NSRGF) Korea’s Samsung Electronics (OTC:SSNLF) – part of a larger group of Samsung brands China’s (and the world’s) largest bank ICBC (OTCPK:IDCBF) Japanese automaker Toyota (TM) Irish medical equipment maker Medtronic (MDT) Royal Dutch Shell, the oil company (RDS.A) Royal Bank of Canada (RY) Spanish bank Santander (SAN), and Hong Kong-based insurer AIA (OTCPK:AAGIY)

    In 11th and 12 place, by market cap, are British telecom Vodafone Plc (VOD) and German automaker BMW (OTCPK:BMWYY), whose brands are valued at 2-4x AIA’s according the map, but whose market caps trade at significantly lower multiples in the current market environment.

great stock investments: Avid Technology Inc.(AVID)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Avid Technology(NASDAQ:AVID) rose 20.3% in April 2017, according to data from S&P Global Market Intelligence.

    So what

    Last month’s share price surge rested on Avid’s release of a coherent cloud-based media production suite. The new version of Avid’s MediaCentral platform takes advantage of the cloud, central storage, and back-end data processing in a way older versions never attempted, modernizing the media production tool in a big way.

  • [By Lisa Levin]

    Avid Technology, Inc. (NASDAQ: AVID) shares were also up, gaining 24 percent to $5.01 following Q3 results. Avid Technology reported Q3 earnings of $0.00 per share on revenue of $105.26 million.

  • [By Monica Gerson]

    Avid Technology, Inc. (NASDAQ: AVID) is estimated to post its quarterly earnings at $0.36 per share on revenue of $144.02 million.

    Consolidated Water Co. Ltd. (NASDAQ: CWCO) is expected to post its quarterly earnings at $0.11 per share on revenue of $15.15 million.

great stock investments: Veeco Instruments Inc.(VECO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, the information technology sector proved to be a source of strength for the market. Leading the sector was strength from QuickLogic Corporation (NASDAQ: QUIK) and Veeco Instruments Inc. (NASDAQ: VECO).

  • [By Paul Ausick]

    Veeco Instruments Inc. (NASDAQ: VECO) dropped nearly 26% Friday to post a new 52-week low of $10.85 after closing at $14.65 on Thursday. The 52-week high is $34.38. Volume was around 5.8 million, about 10 times the daily average of around 584,000. The company reported late yesterday that it had received an unfavorable patent ruling in China.

  • [By WWW.GURUFOCUS.COM]

    VECO (NASDAQ:VECO) contributed 1.16% to the Fund’s quarterly return, nearly equaling AAN’s contribution in the quarter. VECO appreciated over 48% in the quarter due to an acceleration of orders for its key MOCVD tools. These tools are the main manufacturing equipment used to produce LEDs, whether they are for display screens or, increasingly, for lighting products. We estimate that VECO currently has roughly 80% global market share for MOCVD tools used to make LEDs.

Top 5 Stocks To Own Right Now

Review

The chart above clearly illustrates Cal-Maine Foods’ (NASDAQ:CALM) strong correlation to shell egg pricing. To the far right, we can see that there has been a spike since the May 10th revisit to $37 per share price; the stock currently stands around $40.60 per share. The recent return north of $40 per share reflects the first time this has occurred since February 3rd.

Despite Cal-Maine’s stock price action, shell egg prices have remained mostly flat over the past month or so. This raises the question as to why the short-term 10 percent move higher has occurred. Investors need to recognize that stocks closely associated with commodities are highly volatile. This is true for oil, natural gas, meats, grains, as well as shell eggs.

Top 5 Stocks To Own Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Chris Lange]

    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Tuesday following its presentation at the JPMorgan Healthcare Conference. The companys Duchenne muscular dystrophy (DMD) drug, Exondys 51, generated better than expected sales clocking in at $5.4 million in the fourth quarter. Previously, this DMD treatment was approved by the FDA just as recently as September 2016.

  • [By Ben Levisohn]

    After surveying 30 neurologists, Baird’s Brian Skorney and Neena Bitritto-Garg contend that the Street might be underestimating sales of Sarepta Therapeutics (SRPT) Exondys 51 treatment for patients with Duchenne muscular dystrophy. They explain why:

  • [By Lisa Levin]

    Sarepta Therapeutics Inc (NASDAQ: SRPT) shares were also up, gaining 16 percent to $47.52 following the announcement of positive results in its study for the treatment of Duchenne Muscular Dystrophy.

  • [By Dan Caplinger]

    Yet some stocks didn’t participate in the rally, instead contending with negative news of their own. Zoe’s Kitchen (NYSE:ZOES), GOL Lineas Aereas Inteligentes (NYSE:GOL), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Johanna Bennett]

    Will healthinsurers pay for Sarepta Therapeutics (SRPT) Exondys 51?

    Thats a question that several analysts have weighed on today. It appears that payors are still actively evaluating and reevaluating coverage of the Duchenne muscular dystrophy drug Exondys 51.

    Approved by the FDA in September, the drug has met with widespread pushback from insurers like Anthem (ANTM), Humana (HUM) and UnitedHealth Group (UNH) amid concerns about its efficacy. So while Sareptas share price has more than doubled over the past 12 months, it has made a sharp retreat, falling 50% to just under $32 a share since hitting a record high $63.73 a share in late September.

    But Cowen analyst Ritu Baral says the tide maybe turning, arguing that coverage denials wont be permanent.

    As SRPT management and our Neuromuscular Disease panelist indicated to us at our recent Healthcare Conference, payor discussions are continuing regarding Exondys 51 with manageable, increasingly positive feedback. Of the major plans we have seen coverage policies released for, only Anthem (including Blue Cross Blue Shield) had previously denied coverage of Exondys, though patients could petition for coverage via a standard appeal process (see further below). Based on their February Specialty Pharmacy Medical Management Prior Authorization Drug List, it appears Anthem will add Exondys 51 to its prior auth list as of 5/1. We think this is encouraging and indicative of the evolving payor landscape surrounding Exondys 51 and more broadly, DMD. Anthem’s pick-up, together with those such as United, which started coverage on 2/1, support the idea of accelerating new patient starts, suggested by SRPT last week at our Healthcare Conference.

    …But Coverage Denials Persist (For Now), Especially Among Non-Ambulatory Patients. While we think the overwhelming majority of amenable patients will eventually be covered for Exondys 51, we do note several social media anecdote

Top 5 Stocks To Own Right Now: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

Top 5 Stocks To Own Right Now: Vuzix Corporation(VUZI)

Advisors’ Opinion:

  • [By James E. Brumley]

    While the economy’s natural — and recurring — cycles favor different kinds of stocks at different times, not every great trend is necessarily a cyclical one. Sometimes, a trend is rooted in a technological development that changes cultural norms. The advent of the smartphone, for example, has made constant connectivity to the world around part of how we live our daily lives.

    These mega-trends present tremendous opportunities for investors too, provided they’re savvy enough to see them coming and play them the right way.

    One such mega-trend newly underway right now is the proliferation of wearables… devices that meld clothing (often a wrist-worn device) and technology to perform a function that couldn’t be performed otherwise. Much of the same technology that made the smartphone possible are now ushering in wearables.

    It’s not been a smooth beginning. however.

    While the buzz was strong and expectations reached a peak two years ago when Fitbit Inc (NYSE:FIT) was all the rage and in the wake of its IPO, the company’s growth wasn’t to be sustained. The company is struggling to muster any growth now, and FIT shares have fallen to a tenth of their value seen in late-2015, when the euphoria was strongest.

    Fitbit’s slowdown has been mirrored by other companies in the space. The wearables market only grew 3.1% in Q3 of 2016.

    On the flipside, while the debacle of Fitbit — the wearable industry’s iconic company — has been a painful, it’s also been a learning experience. And, it’s not as if the slowdown is unfurling without the wearables market never reaching a respectable size. International Data Corporation estimates were 23 million ‘wearables’ delivered in the third quarter of last year alone.

    Moreover, the fizzling of the market hasn’t turned into a reason to swear off wearables as an investment opportunity… quite the opposite, actually. It’s just now become considerably clearer what consumers want an

  • [By William Patalon III]

    Vuzix Corp. (Nasdaq: VUZI) – the “augmented reality” company whose shares more than doubled following our September 2015 recommendation – said that its new “smart glasses” were just honored with a “Wearable Device of the Year” award.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top 5 Stocks To Own Right Now: Cotiviti Holdings, Inc. (COTV)

Advisors’ Opinion:

  • [By Scott Rubin]

    Big gainers on the day included Intersil Corp (NASDAQ: ISIL), which jumped 20 percent on news of a buyout, and Medivation (NASDAQ: MDVN), which added 20 percent on a deal with Pfizer (NYSE: PFE) related to its cancer drug. Cotiviti Holdings Inc (NYSE: COTV) lost around 9 percent in the wake of a mid-day sell-off and Marathon Oil Corporation (NYSE: MRO) fell 7 percent in the wake of a management shakeup.

Top 5 Stocks To Own Right Now: Guaranty Bancorp(GBNK)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PATRIOT FINANCIAL PARTNERS GP, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PATRIOT+FINANCIAL+PARTNERS+GP%2C+LP

    These are the top 5 holdings of PATRIOT FINANCIAL PARTNERS GP, LPBanc of California Inc (BANC) – 2,850,564 shares, 27.82% of the total portfolio. Guaranty Bancorp (GBNK) – 1,891,767 shares, 23.36% of the total portfolio. Shares reduced by 19.22%Meta Financial Group Inc (CASH) – 347,069 shares, 14.02% of the total portfolio. Sterling Bancorp (STL) – 1,048,980 shares, 11.07% of the total portfolio. Shares reduced by 16.01%MBT Financial Corp (MBTF) – 2,060,302 sha

stock technical analysis

Source: ThinkstockMay 23, 2017: The S&P 500 closed higher on the day, up 0.2% at 2,398.45. Separately the DJIA closed up 0.2% as well at 20,938.59. The Nasdaq closed relatively flat at 6,138.71.

Although the broad markets had a positive day even if it was only slightly. Crude oil continued to push higher again on Tuesday back above $50 and now above $51. The main drag on the markets that kept them from pushing higher was retailers and a handful of tech stocks. Otherwise, the S&P 500 sectors were more or less positive across the board with a few exceptions. We saw the biggest gains in financial stocks and health care stocks. While crude was posting another strong day, oil & gas stocks were only slightly higher.

Crude oil broke the $50 level Monday and continued even higher on Tuesday. Crude was last trading higher on the day up 0.6% at $51.44.

stock technical analysis: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

stock technical analysis: Maximus, Inc.(MMS)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).

    The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.

    “MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”

    Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.

  • [By ]

    Maximus Inc (NYSE: MMS) holds just $16 million in long-term debt against $886 million in shareholder equity. Shares trade for 1.7 times sales for a discount of 26% on the industry average of 2.3 times sales.

stock technical analysis: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

stock technical analysis: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

stock technical analysis: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares were also up, gaining 17 percent to $39.80. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.

  • [By Chris Lange]

    Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) has announced preliminary unaudited total revenues and net product sales for Exparel for the fourth quarter and the full year. Total revenues were $72.9 million and $276.4 million for the fourth quarter and full year, respectively. Exparel net product sales were $71.4 million and $239.9 million for the same periods, respectively. The consensus estimates from Thomson Reuters were calling for revenues of $72.56 million in the fourth quarter and $276.09 million in the full year.

best penny stocks

(Photo Credit: Zach Gibson/Bloomberg)

Eighteen Democratic attorneys general from 18 states, plus the District of Columbia, sued U.S. Secretary of Education Betsy DeVos and the Department of Education for delaying certain borrower protection rules that were scheduled to take effect beginning July 1.

The lawsuit was filed in federal district court in Washington, D.C. and alleges that DeVos illegally delayed the implementation of the borrower defense to repaying rules, which make it easier for defrauded student loan borrowers to receive student loan debt forgiveness.

The attorneys general claim that DeVos violated the Administrative Procedures Act because she did not meet the standard for a delay, give proper notice or afford adequate time for public comment. The lawsuit asks the court to implement the borrower defense rules promptly.

best penny stocks: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

best penny stocks: Valmont Industries, Inc.(VMI)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Masco (MAS) , American Electric Power (AEP) and Valmont Industries (VMI) .

    Cramer was bearish on Wisconsin Energy (WEC) .

best penny stocks: Hexcel Corporation(HXL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Hexcel Corporation (NYSE: HXL) issued a weak profit and sales forecast for 2017.
    VeriFone Systems Inc (NYSE: PAY) reported better-than-expected earnings for its fourth quarter, but issued a weak outlook for the first quarter.
    Boeing Co. (NYSE: BA) lifted its quarterly dividend by 30 percent to $1.42 per share. The company’s board also announced a a new $14 billion share buyback plans.
    Inovalon Holdings Inc (NASDAQ: INOV) cut its earnings and revenue guidance for full year 2016.

best penny stocks: Wabash National Corporation(WNC)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of Wabash National Corporation (NYSE:WNC) jumped 10.1% in April, according to data provided by S&P Global Market Intelligence, after the company reported its first-quarter 2017 results.

best penny stocks: Endeavour Silver Corporation(EXK)

Advisors’ Opinion:

  • [By Manikandan Raman]

    Citing bullish outlook on silver prices, Peter Bures of Canaccord Genuity has started coverage of four silver producers: Pan American Silver Corp. (USA) (NASDAQ: PAAS), Coeur Mining Inc (NYSE: CDE), Hecla Mining Company (NYSE: HL), and Endeavour Silver Corp (NYSE: EXK). The brokerage also assumed coverage of Fortuna Silver Mines Inc (NYSE: FSM) with a Buy rating.

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.66 percent. Meanwhile, top losers in the sector included Endeavour Silver Corp (NYSE: EXK), down 22 percent, and Greif, Inc. (NYSE: GEF), down 10 percent.

  • [By Lisa Levin]

    On Monday, basic materials shares surged by 1.1 percent. Top gainers in the sector included Cliffs Natural Resources Inc (NYSE: CLF) and Endeavour Silver Corp (NYSE: EXK).

  • [By Lisa Levin]

    Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).

best penny stocks: Revlon, Inc.(REV)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

  • [By Jeremy Bowman]

    Shares of Revlon, Inc.(NYSE:REV) surged last month after the company announced a restructuring plan. According to data from S&P Global Market Intelligence, the stock gained 15%. The bulk of the increase came in the middle of the month when the restructuring plan was announced.

Top 5 Undervalued Stocks To Invest In 2018

Russ Kaplan is a leading money manager with a value-oriented and contrarian approach to very long-term investing; here’s a look at his top growth idea for the coming year.

One of the few places of value in this market is the home building stocks and our Top Pick for growth-oriented investors is D. R. Horton (DHI), which is a home building stock.

D.R. Horton is more than just a homebuilder, however. Horton is involved in all aspects of the realty area. It also owns lots of property and is into title insurance.

Yes, mortgage rates have gone up, but that is already reflected in the price of the stock, which has fallen from $38 to a recent price is the $28 range. I can see it going back to $38 in the near future.

With a price/earnings ratio of 12, it is very undervalued from the market average, which is currently around 22.

There really is a D. R. Horton and he owns 7% of the company. This is not a stock for those looking for income. It only pays a little over 1%.

Top 5 Undervalued Stocks To Invest In 2018: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

Top 5 Undervalued Stocks To Invest In 2018: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By Phil Saunders]

    Vitality Biopharma, Inc. (OTCBB: VBIO) recent ascent as a strong small cap player in Cannabis pharma, is part of a boom in Cannabis-based pharmaceuticals making announcements about unique and innovative delivery systems being tested for such ailments as Epilepsy, Multiple Sclerosis, and Crohns disease. But it is important to understand how the industry is evolving in the United States and Canada and what that might mean when realizing valuation and the evolution of government policies which still vary from jurisdiction to jurisdiction, making access to Cannabis and the pricing model still a big question moving forward.

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

  • [By James E. Brumley]

    In mid-September, Vitality Biopharma Inc (OTCMKTS:VBIO) announced it was going to take aim at the development of an alternative to opioids as a means of treating pain. At the time, there was little doubt that the company’s cannabinoid science was capable of doing so. What wasn’t clear to VBIO shareholders was exactly how that might happen…. meaning what sort of drug might Vitality Biopharma come up with.

    We got the first of what will likely be several answers to the question today. Per today’s press release, Vitality Biopharma intends to come up with a treatment for narcotic bowel syndrome, which is a severe form of (ironically enough) opiate-induced abdominal pain.

    As a refresher, Vitality Biopharma was the name we introduced to you back on August 8th, pointing out it had developed a whole new way of making cannabinoid-based medicines. Their versions offer all the upsides of cannabinoids, but without the psychotropic (“getting high’) effects, and without some of the common downsides associated with these pharmaceuticals… like mouth and skin lesions.

    There are even bigger advantages to Vitality Biopharma’s science, however. Namely, since these drugs are prodrugs and aren’t activated until in the body, they allow for targeted delivery to the GI tract (yet can also selectively target other body parts, even as far away from the GI tract as the brain). Perhaps more than anything though, these drugs are orally-administered by virtue of being highly soluble, making them easy to use.

    It’s this nuance that makes Vitality Biopharma’s recently-announced intention so interesting, and compelling.

    Studies have found that up to 81% of patients treated with opiates have functional bowel disorders, with more than half — 58% to be exact — of opiate users reporting chronic abdominal pain stemming from the use of their prescribed painkillers. Considering 200 million opioid prescriptions are filled every year in the United States alo

Top 5 Undervalued Stocks To Invest In 2018: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

Top 5 Undervalued Stocks To Invest In 2018: Applied Micro Circuits Corporation(AMCC)

Advisors’ Opinion:

  • [By Piyush Arora]

    AMD, along with other server-grade chip manufacturers such as Qualcomm (NSDQ:QCOM), Cavium (NSDQ:CAVM) and AMCC (NSDQ:AMCC), operates in the remaining minuscule 0.8% of the market. So, each of the aforementioned companies operate with a practically non-existent market share, compared to Intels shipments of course. This also means that these firms (AMD, Qualcomm etc.) have plenty of room to grow. This would be subject to good product releases of course, but at least this way, the law of large numbers isnt working against them.

Top 5 Undervalued Stocks To Invest In 2018: Bridgford Foods Corporation(BRID)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, non-cyclical consumer goods & services shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Medifast Inc (NYSE: MED), down 5 percent, and Bridgford Foods Corporation (NASDAQ: BRID), down 6 percent.

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

rolling stocks

The U.S. Department of Agriculture’s cattle-on-feed report was just released.

The USDA report showed cattle and calves on feed for the slaughter market totaled 10.165 million head on August 1st, up 2 percent versus August 1st, 2015. Placements in feedlots during July totaled 1.572 million head, up 2 percent versus a year ago. Marketings of fed cattle during July totaled 1.713 million head, down 1 percent from last year.

Posted-In: USDA Cattle on Feed ReportFutures Commodities Markets

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 
Related Articles Intel To Develop Autonomous Vehicle Solution To Compete Against Nvidia, Mobileye; CLSA Remains Unimpressed CNN's Paul La Monica Talks Target, E-Commerce And The Retail Sector With Benzinga

rolling stocks: BlackBerry Limited(BBRY)

Advisors’ Opinion:

  • [By Kumar Abhishek]

    Yesterday, software and services company BlackBerry (NSDQ:BBRY)released its Q3 2017 earnings report. It was Blackberry’s first earnings after the company decided to shut down its legacy handset division. The earnings report appears to be more of the same. The Waterloo, Ontario-based company once again reported an earnings beat and a miss on revenues. The company reported a Non-GAAP EPS of $0.01 on revenue of $301 million against the analysts’ estimates of -$0.02 EPS on revenue of $332 million. BlackBerry stock rallied more than 3% just after the earnings were announced in pre-market trading.However, the stock moved lower as the market began to digest the ER, closing down by almost 3%.

  • [By Kumar Abhishek]

    The Canadian software firm, BlackBerry (NSDQ:BBRY), is scheduled to release its Q3 2017 earnings report on Tuesday, 20th of December. This will be the first earnings since the company dumped its handset business and became a software company, one of the boldest move of its turnaround strategy. During the quarter, BlackBerry launched two handsets, DTEK50 and DTEK60 and entered into an agreement with Ford to expand the usage of its QNX software by providing a secure infotainment solution. BlackBerry is also making strong moves into MedTechcybersecurity.

  • [By Kumar Abhishek]

    Shares of Ontario-basedsoftware companyBlackBerry Ltd (NASDAQ:BBRY) jumped more than 16% in yesterday’s trade,creating a new 52-week highafter the company announced that it has won a windfall of $814.9 million in an interim arbitrationaward against Qualcomm (NASDAQ:QCOM).Moreover, the arbitration award is not appealable by Qualcomm. The final award which will include interest rates and legal fees will be decided on May 31st. The windfall gain has earned BBRY stock price target upgrades from several analysts. The arbitration relates to an overpayment of royalty by BlackBerry Ltd between 2010 and 2015. The question now is, does this one-time award change anything for BlackBerry Ltd stock?

  • [By Lisa Levin]

    BlackBerry Ltd (NASDAQ: BBRY) reported an unexpected profit for the first quarter. However, sales trailed expectations. The company also announced a stock buyback program.

  • [By WWW.THESTREET.COM]

    For those remaining QWERTY keyboard aficionados out there, BlackBerry (BBRY)  hardware partner TCL launched the BlackBerry KeyOne, a phone that pairs a 4.5-inch display with a physical keyboard and BlackBerry apps/services. It sells for $549 unsubsidized.

  • [By WWW.GURUFOCUS.COM]

    For the details of RABOBANK NEDERLAND ‘s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=RABOBANK+NEDERLAND+

    These are the top 5 holdings of RABOBANK NEDERLAND Bank of America Corporation (BAC) – 250,000 shares, 100% of the total portfolio. New PositionBlackBerry Ltd (BBRY) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%iShares MSCI Emerging Index Fund (EEM) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%iShares MSCI Brazil Capped Index Fund (EWZ) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%VanEck Vectors Gold Miners (GDX) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%

rolling stocks: Atlantic Power Corporation(AT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included Atlantic Power Corp (NYSE: AT), down 2 percent, and Pampa Energia S.A. (ADR) (NYSE: PAM), down 4 percent.

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included Atlantic Power Corp (NYSE: AT), down 2 percent, and SCANA Corporation (NYSE: SCG) down 1 percent.

  • [By Lisa Levin] Related WR Earnings Scheduled For February 24, 2016 Mid-Day Market Update: Ocata Therapeutics Climbs On Acquisition News; Textura Shares Slip
    Related AT Mid-Morning Market Update: Markets Open Higher; Tiffany Misses Q2 Expectations PVH Corp, Atlantic Power, Carlyle Group Lead Monday's After-Hours Movers Atlantic Power's (AT) CEO Jim Moore on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)

    Toward the end of trading Thursday, the Dow traded down 0.24 percent to 16,960.40 while the NASDAQ declined 0.38 percent to 4,656.49. The S&P also fell, dropping 0.17 percent to 1,985.91.

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares slipped by 0.02 percent. Meanwhile, top losers in the sector included Companhia de Saneamento Basico (ADR) (NYSE: SBS), down 3 percent, and Atlantic Power Corp (NYSE: AT), down 3 percent.

rolling stocks: SPAR Group Inc.(SGRP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested going long on small cap international merchandising and marketing services stockSPAR Group Inc (NASDAQ: SGRP):

rolling stocks: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.